Viral Hepatitis C - }

}
SUSTAINED ALT RESPONSE RATE VS DURATION OF THERAPY IN CHRONIC HEPATITIS C PATIENTS INTRON A 3 Million IU TIW Treatment Group* Number of Patients (%) INTRON A 3 million IU Difference

Management of Chronic Hepatitis C: Clinical Focus
Management of Chronic Hepatitis C Summary (Publication No. 02-E029, June 2002) Evidence Report (Publication No. 02-E030, June 2002) ( PDF File , 2.3 MB) Evidence-based Practice Center: Johns Hopkins

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073] Find a Clinical Trial Full Title : SHO-SAIKO-TO FOR PATIENTS WITH CHRONIC HEPATITIS